{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:06:46Z","timestamp":1777536406760,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,8,21]],"date-time":"2010-08-21T00:00:00Z","timestamp":1282348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11096-010-9430-9","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T03:33:25Z","timestamp":1282275205000},"page":"737-743","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Tomoya","family":"Sakurada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisae","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobunori","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,21]]},"reference":[{"key":"9430_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmj.299.6692.150","volume":"299","author":"JM Potter","year":"1989","unstructured":"Potter JM, Reid DB, Shaw RJ, Hackett P, Hickmann PE. Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. Br Med J. 1989;299:150\u20133.","journal-title":"Br Med J"},{"key":"9430_CR2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3959(92)90146-3","volume":"49","author":"JH Eisele","year":"1992","unstructured":"Eisele JH, Grisby EJ, Den G. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain. 1992;49:213\u201332.","journal-title":"Pain"},{"key":"9430_CR3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(93)90188-U","volume":"55","author":"P Sjogren","year":"1993","unstructured":"Sjogren P, Jonsson T, Jensen NH, Drenck NE, Jensen TS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain. 1993;55:93\u20137.","journal-title":"Pain"},{"key":"9430_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","volume":"59","author":"P Sjogren","year":"1994","unstructured":"Sjogren P, Jensen NH, Jensen TS. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain. 1994;59:313\u20136.","journal-title":"Pain"},{"key":"9430_CR5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000539-199512000-00034","volume":"81","author":"S Mercadante","year":"1995","unstructured":"Mercadante S. Dantrolene treatment of opioid-induced myoclonus. Anesth Analg. 1995;81:1307\u20138.","journal-title":"Anesth Analg"},{"key":"9430_CR6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3565(25)30761-5","volume":"200","author":"K Iwamoto","year":"1977","unstructured":"Iwamoto K, Klaassen CD. First-pass effect of morphine in rats. J Pharmacol Exp Ther. 1977;200:236\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"9430_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00611908","volume":"14","author":"KW Bock","year":"1978","unstructured":"Bock KW, Brunner G, Hoensch M, Huber E, Josting D. Determination of microsomal UDP-glucuronyl transferase in needle-biopsy specimens of human liver. Eur J Clin Pharmacol. 1978;14:367\u201373.","journal-title":"Eur J Clin Pharmacol"},{"key":"9430_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(25)20832-1","volume":"251","author":"D Paul","year":"1989","unstructured":"Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989;251:477\u201383.","journal-title":"J Pharmacol Exp Ther"},{"key":"9430_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3565(25)10743-X","volume":"262","author":"B Frances","year":"1992","unstructured":"Frances B, Gout R, Monsarrat B, Cros J, Zajac J-M. Further evidence that morphine-6-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ther. 1992;262:25\u201331.","journal-title":"J Pharmacol Exp Ther"},{"key":"9430_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/03602539608994011","volume":"28","author":"RW Milne","year":"1996","unstructured":"Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev. 1996;28:345\u2013472.","journal-title":"Drug Metab Rev"},{"key":"9430_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(79)90849-7","volume":"174","author":"FS Labella","year":"1979","unstructured":"Labella FS, Pinsky C, Havlicek V. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res. 1979;174:263\u201371.","journal-title":"Brain Res"},{"key":"9430_CR12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0024-3205(98)00288-4","volume":"63","author":"AWE Wright","year":"1998","unstructured":"Wright AWE, Nocente M-L, Smith MT. Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation. Life Sci. 1998;63:401\u201311.","journal-title":"Life Sci"},{"key":"9430_CR13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000542-198605000-00008","volume":"64","author":"TL Yaksh","year":"1986","unstructured":"Yaksh TL, Harty GJ, Onofrio BM. High doses of spinal morphine produce a non-opiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology. 1986;64:590\u20137.","journal-title":"Anesthesiology"},{"key":"9430_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0024-3205(94)00552-4","volume":"54","author":"SE Bartlett","year":"1994","unstructured":"Bartlett SE, Cramond T, Smith MT. The excitatory effects of M3G are attenuated by LY274614, a competitive NMDA receptor antagonist and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sci. 1994;54:68\u201394.","journal-title":"Life Sci"},{"key":"9430_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.867056","volume":"197","author":"G Urca","year":"1977","unstructured":"Urca G, Frenk H, Liebeskind J, Taylor A. Morphine and enkephalin: analgesic and epileptic properties. Science. 1977;197:83\u20136.","journal-title":"Science"},{"key":"9430_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-8993(81)90176-1","volume":"209","author":"C Woolf","year":"1981","unstructured":"Woolf C. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res. 1981;209:491\u20135.","journal-title":"Brain Res"},{"key":"9430_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","volume":"47","author":"MT Smith","year":"1990","unstructured":"Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide\u2014a potent antagonist of morphine analgesia. Life Sci. 1990;47:579\u201385.","journal-title":"Life Sci"},{"issue":"10","key":"9430_CR18","first-page":"989","volume":"62","author":"RC Aitken","year":"1969","unstructured":"Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Lond. 1969;62(10):989\u201393.","journal-title":"Proc R Soc Lond"},{"key":"9430_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-4347(00)00146-8","volume":"742","author":"QC Meng","year":"2000","unstructured":"Meng QC, Cepeda MS, Kramer T, Zou H, Matoka DJ, Farrar J. High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites by two-step solid-phase extraction. J Chromatogr B Biomed Sci Appl. 2000;742:115\u201323.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"9430_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0731-7085(01)00393-4","volume":"26","author":"K Arty","year":"2001","unstructured":"Arty K, R\u00f3na K. LC determination of morphine and morphine glucuronides in human plasma by coulometric and UV detection. J Pharm Biomed Anal. 2001;26:179\u201387.","journal-title":"J Pharm Biomed Anal"},{"key":"9430_CR21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0731-7085(96)01911-5","volume":"15","author":"M Freiermuth","year":"1997","unstructured":"Freiermuth M, Plasse JC. Determination of morphine and codeine in plasma by HPLC following solid phase extraction. J Pharm Biomed Anal. 1997;15:759\u201364.","journal-title":"J Pharm Biomed Anal"},{"key":"9430_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2005.10.016","volume":"161","author":"P Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez P, Morales L, V\u00e1zquez C, Bermejo AM, Tabernero MJ. HPLC-DAD determination of opioids, cocaine and their metabolites in plasma. Forensic Sci Int. 2006;161:31\u20135.","journal-title":"Forensic Sci Int"},{"key":"9430_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jchromb.2005.06.008","volume":"822","author":"D Groenendaal","year":"2005","unstructured":"Groenendaal D, Blom-Roosemalen MC, Danhof M, Lange EC. High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic\/pharmacodynamic studies in rats. J Chromatogr B Anal Technol Biomed Life Sci. 2005;822:230\u20137.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"703","key":"9430_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-4347(97)00384-8","volume":"5","author":"MJ Bogusz","year":"1997","unstructured":"Bogusz MJ, Maier RD, Erkens M, Driessen S. Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Biomed Sci Appl. 1997;5(703):115\u201327.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"9430_CR25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/bmc.516","volume":"19","author":"O Cheremina","year":"2005","unstructured":"Cheremina O, Bachmakov I, Neubert A, Brune K, Fromm MF, Hinz B. Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2005;19:777\u201382.","journal-title":"Biomed Chromatogr"},{"key":"9430_CR26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jms.1021","volume":"41","author":"F Musshoff","year":"2006","unstructured":"Musshoff F, Trafkowski J, Kuepper U, Madea B. An automated and fully validated LC-MS\/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J Mass Spectrom. 2006;41:633\u201340.","journal-title":"J Mass Spectrom"},{"key":"9430_CR27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2006.09.006","volume":"11","author":"OM Fredheim","year":"2007","unstructured":"Fredheim OM, Borchgrevink PC, Klepstad P, Kaasa S, Dale O. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects. Eur J Pain. 2007;11:599\u2013604.","journal-title":"Eur J Pain"},{"key":"9430_CR28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.102.035626","volume":"302","author":"TD Moran","year":"2002","unstructured":"Moran TD, Smith PA. Morphine-3 beta-d-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa. J Pharmacol Exp Ther. 2002;302:568\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9430_CR29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1213\/01.ANE.0000059225.40049.99","volume":"97","author":"K Hemstapat","year":"2003","unstructured":"Hemstapat K, Monteith GR, Smith D, Smith MT. Morphine-3-glucuronide\u2019s neuro-excitatory effects are mediated via indirect activation of N-methyl-d-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones. Anesth Analg. 2003;97(2):494\u2013505.","journal-title":"Anesth Analg"},{"issue":"1","key":"9430_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(94)00228-7","volume":"62","author":"GD Smith","year":"1995","unstructured":"Smith GD, Smith MT. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat. Pain. 1995;62(1):51\u201360.","journal-title":"Pain"},{"key":"9430_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3959(96)03112-0","volume":"67","author":"A Vigano","year":"1996","unstructured":"Vigano A, Fan D, Bruera E. Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain. 1996;67:115\u20139.","journal-title":"Pain"},{"key":"9430_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1213\/00000539-199307000-00038","volume":"77","author":"AJ Armendi De","year":"1993","unstructured":"De Armendi AJ, Fahey M, Ryan JF. Morphine-induced myoclonic movements in a pediatric pain patient. Anesth Analg. 1993;77:191\u20132.","journal-title":"Anesth Analg"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-010-9430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-010-9430-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-010-9430-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T20:45:15Z","timestamp":1740429915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-010-9430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,21]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9430"],"URL":"https:\/\/doi.org\/10.1007\/s11096-010-9430-9","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,21]]}}}